CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study. Merle, B.; Richard, F; Benlian, P; Puche, N; Delcourt, C; and Souied, E. PLoS One, 10:e0130816, 2015.
doi  bibtex   
@article{merle_cfh_2015,
	title = {{CFH} {Y402H} and {ARMS2} {A69S} {Polymorphisms} and {Oral} {Supplementation} with {Docosahexaenoic} {Acid} in {Neovascular} {Age}-{Related} {Macular} {Degeneration} {Patients}: {The} {NAT2} {Study}.},
	volume = {10},
	issn = {1932-6203},
	doi = {10.1371/journal.pone.0130816},
	language = {English},
	journal = {PLoS One},
	author = {Merle, BM and Richard, F and Benlian, P and Puche, N and Delcourt, C and Souied, EH},
	year = {2015},
	pages = {e0130816}
}
Downloads: 0